La herramienta de evaluación de la cadena de suministro de Zithromax® está diseñada para guiar a los miembros del equipo de
evaluación a través de una serie de entrevistas con informantes clave y para establecer procedimientos de inspección al realizar
evaluaciones de la logística. El prot...ocolo permite al equipo de evaluación, examinar la preparación del Programa Nacional de Control del Tracoma y las estructuras de gestión de salud a nivel de Distrito para recibir, gestionar, distribuir y administrar el Zithromax® donado para la administración masiva de medicamento
more
Análisis de las inequidades en salud reproductiva, materna, neonatal, de la niñez y de la adolescencia en América Latina y el Caribe para guiar la formulación de políticas
Trop. Med. Infect. Dis. 2022, 7, 152. https://doi.org/10.3390/tropicalmed7080152
23 April 2020EMA/202483/2020 Rev
Chloroquine and hydroxychloroquine are known to potentially cause heart rhythm problems, and these could be exacerbated if treatment is combined with other medicines, such as the antibiotic azithromycin, that have similar effects on the heart.
This document aims to present an algorithm for deciding whom to test and provide guidance on the laboratory tests for Zika virus infection diagnosis in order to support clinical diagnostic and case reporting through surveillance among EU Member States. The algorithm is not intended for clinical man...agement of patients with suspected Zika virus infection.
The information is provisional and subject to revision when new information becomes available.
more
THELANCETID-D-16-00800 S1473-3099(16)30318-8
Sustainability 2020, 12, 1025
THE RESEARCH FOUNDATION OF CEREBRAL PALSY ALLIANCE newsletter – NOVEMBER 2012
Standard Treatment Guidelines
Morbidity and Mortality Weekly Report (MMWR):
Zika and dengue viruses remain significant public health threats. These viruses share the same Aedes (Stegomyia) mosquito vectors and geographic distributions but infections cannot be readily distinguished clinically and need to be differentiated from each other, and from other circulating arboviral... and non-arboviral pathogens, using laboratory tests. This document provides guidance on current testing strategies for Zika and dengue virus infections with updates to the previous interim guidance for laboratory testing for ZIKV, addressing pregnant and non-pregnant patients respectively, and incorporates current guidance for dengue virus diagnostic testing. The choice of laboratory assays and interpretation of test results require careful consideration of epidemiology, patient history, and limitations of existing diagnostic tests.
This interim guidance is for use by staff of laboratories testing for Zika and dengue virus infections and for clinical practitioners and public health professionals providing clinical management or surveillance.
more
Infographic
Health workers play a key role in ensuring the continued safety of COVID-19 vaccines